This division supports the development and demonstration of modular platform technologies (without preference for any disease or application) that manipulate and interface with biology to enable new paradigms of clinical intervention for human health.
Division of Discovery Science & Technology (Bioengineering)
Grantee News ·Researchers have generated synthetic mucins with a polymer backbone that more accurately mimics the structure and function of naturally occurring mucins. They also showed that these synthetic mucins could effectively neutralize the bacterial toxin that causes cholera.
Grantee News ·Sickle cell disease is the most prevalent inherited blood disorder in the world, affecting 70,000 to 100,000 Americans. However, it is considered an orphan disease, meaning it impacts less than 200,000 people nationally, and is therefore underrepresented in therapeutic research.
Grantee News ·In Made of Stronger Stuff, psychologist Kimberley Wilson and doctor Xand van Tulleken learn how Jason became the first person in the world with a neural enabled prosthetic hand, and as a result, regained the sensation of touch in his fingers. Source: BBC Radio Podcast.
Press Releases ·An NIH-funded research team has launched a study to assess performance and usability of a smartphone app paired with the Quidel QuickVue At-Home COVID-19 Test, which received FDA emergency use authorization for use with a prescription.
Grantee News ·Vascular and interventional radiologists report the development of a new ionic liquid formulation that killed cancer cells and allowed uniform distribution of a chemotherapy drug into liver tumors and other solid tumors in the lab. This discovery could solve a problem that has long plagued drug delivery to tumors.